Journal
MOLECULAR IMMUNOLOGY
Volume 112, Issue -, Pages 72-81Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.molimm.2019.04.019
Keywords
Sepsis; Immune suppression; MDSC; S100A9
Categories
Funding
- National Institutes of Health [R01GM103887, C06RR0306551]
Ask authors/readers for more resources
Myeloid-derived suppressor cells (MDSC) expand during sepsis, suppress both innate and adaptive immunity, and promote chronic immunosuppression, which characterizes the late/chronic phase of sepsis. We previously reported that the transcription factors Stat3 and C/EBP13 synergize to induces the expression of microRNA (miR)21 and miR-181b to promote MDSC expansion in a mouse model of polymicrobial sepsis that progresses from an early/acute proinflammatory phase to a late/chronic immunosuppressive stage. We also showed that Gr1(+)CD11b(+) cells, the precursors of MDSCs, from mice genetically deficient in the inflammatory protein S100A9 lack miR-21 or miR-181b in late sepsis, and are not immunosuppressive. In the present study, we show that S100A9 induces miR-21 and miR-181b during the late sepsis phase. We find that S100A9 associates with and stabilizes the Stat3-C/EBP beta protein complex that activates the miRNA promoters. Reconstituting Gr1(+)CD11b(+) cells from S100A9 knockout mice with late sepsis with S100A9 protein restores the Stat3-C/EBP beta protein complex and miRNA expressions, and switches the Gr1(+)CD11b(+) cells into the immunosuppressive, MDSC phenotype. Importantly, we find that this process requires IL-10 mediated signaling, which induces S100A9 translocation from the cytosol to the nucleus. These results demonstrate that S100A9 promotes MDSC expansion and immunosuppression in late/chronic sepsis by inducing the expression of miR-21 and miR-181b.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available